# Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

> **NCT06810375** · PHASE3 · RECRUITING · sponsor: **George Washington University** · enrollment: 120 (estimated)

## Conditions studied

- Lung Cancers

## Interventions

- **DRUG:** Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
- **DRUG:** Intercostal nerve block

## Key facts

- **NCT ID:** NCT06810375
- **Lead sponsor:** George Washington University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2028-02-28
- **Final completion:** 2029-02-28
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06810375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06810375, "Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06810375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*